Current News
2025
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2024
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2023
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2022
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2021
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2020
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2019
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2018
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2016
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2015
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2014
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2013
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2012
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2011
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”2010
Walbrook PR - Spectral MD
04 July 2022
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.
The Best Technology award is awarded for a technology that is innovative, well-funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organisation or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: “I was delighted to collect the award on behalf of the Spectral MD team. The award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honoured to be recognised on an international stage at such a prestigious event.”
.jpg "Fusion Antibodies - Landscape (Trimmed)")
.png "MyHealthChecked PLC_Logo_2 Line_Colour_Red_RGB_AW (003)"){kind=logo}
